National Biological Corp. makes FDA-cleared phototherapy devices for treating skin conditions such as psoriasis, eczema, and vitiligo.
Founded in 1967 in Beachwood, US, National Biological Corp. develops phototherapy products for dermatological care, including home UVB systems such as the DermaPal and Dermalume 2X and clinical systems for healthcare providers. Devices are sold direct-to-consumer, with purchase or financing options, and through business-to-business channels in the United States and select international markets. Madison Industries acquired the company in June 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in